NFKB1 and gestational diabetes: Inhibition of TLR4 signaling has been shown to stimulate insulin secretion, and downregulation of the TLR4/MyD88/NF-κB pathway can alleviate oxidative stress and decrease inflammatory cytokines during GDM (76).